Evidence map›Paper›PMID 34233920›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2021

Classification of Uremic Toxins and Their Role in Kidney Failure.

Mitchell H Rosner, Thiago Reis, Faeq Husain-Syed, Raymond Vanholder, Colin Hutchison, Peter Stenvinkel, Peter J Blankestijn, Mario Cozzolino, Laurent Juillard, Kianoush Kashani and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 2 pooled it
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 2 syntheses or guidelines pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 16 institutions in 13 countries.

Mitchell H RosnerDivision of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
Thiago ReisDepartment of Nephrology, University of Brazil, Brasília, Brazil.ORCID 0000-0002-7071-117
Faeq Husain-SyedDepartment of Internal Medicine II, Justus-Liebig-University Giessen, Giessen, Germany.
Raymond VanholderDepartment of Internal Medicine and Pediatrics, University Hospital, Ghent, Belgium.ORCID 0000-0003-2633-1636
Colin HutchisonFaculty of Medicine, University of Queensland, Herston, Australia.
Peter StenvinkelRenal Medicine, Karolinska University Hospital, Stockholm, Sweden.
Peter J BlankestijnDepartment of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands.
Mario CozzolinoRenal Division, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-8494-6252
Laurent JuillardUniversity of Lyon, Villeurbanne, France.
Kianoush KashaniDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-2184-3683
Manish KaushikDepartment of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
Hideki KawanishiDepartment of Artificial Organs, Tsuchiya General Hospital, Hiroshima, Japan.
Ziad MassyINSERM U1018, Villejuif, France.
Tammy Lisa SirichNephrology Section, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Li ZuoDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Claudio RoncoDepartment of Medicine, University of Padova, Padova, Italy.ORCID 0000-0002-6697-4065
Ghent University Hospital · BEHiroshima General Hospital · JPInserm · FRJustus-Liebig-Universität Gießen · DEKarolinska University Hospital · SEMayo Clinic · USPeking University · CNSingapore General Hospital · SGThe University of Queensland · AUUniversidade de Brasília · BRUniversité Claude Bernard Lyon 1 · FRUniversity Medical Center Utrecht · NLUniversity of Milan · ITUniversity of Padua · ITUniversity of Virginia Health System · USVA Palo Alto Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classification of uremic toxins. A consensus conference was held to develop recommendations for an updated definition and classification scheme on the basis of a holistic approach that incorporates physicochemical characteristics and dialytic removal patterns of uremic retention solutes and their linkage to clinical symptoms and outcomes. The major focus is on the removal of uremic retention solutes by hemodialysis. The identification of representative biomarkers for different classes of uremic retention solutes and their correlation to clinical symptoms and outcomes may facilitate personalized and targeted dialysis prescriptions to improve quality of life, morbidity, and mortality. Recommendations for areas of future research were also formulated, aimed at improving understanding of uremic solutes and improving outcomes in patients with CKD.

Indexed as

Renal InsufficiencyToxins, BiologicalUremiaHumansQuality of LifeRenal DialysisUremic ToxinsToxins, BiologicalUremic Toxinsclassificationdefinitiondialysismiddle moleculeuremia

Identifiers

PMID34233920
PMCPMC8729494
OpenAlexW3177646722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.